| Name | GPX4-IN-5 |
|---|
| Description | GPX4-IN-5 (Compound C18) is a GPX4 covalent inhibitor with an IC50 value of 0.12 μM. GPX4-IN-5 (Compound C18) can induce ferroptosis for the research of triple-negative breast cancer (TNBC) [1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.12 μM (GPX4)[1] |
| References |
| Molecular Formula | C18H17ClFNO5 |
|---|---|
| Molecular Weight | 381.78 |